Kira J. Stanzick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kira J. Stanzick has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Adriana M. Hung
Department of Veteran’s Affairs, Tennessee Valley Healthcare System (626)/Vanderbilt University, Nashville, USA
1 shared publicationAndre Gessner
Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany
1 shared publication- Anna Köttgen
Institute of Genetic Epidemiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
1 shared publication - Bjørn Olav Åsvold
HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway
1 shared publication Brett R. Vanderweff
Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, USA
1 shared publicationBryce X. Rowan
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, USA
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 16 July 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-17
Discovery and prioritization of variants and genes for kidney function in >1.2 million individuals
Genes underneath signals from genome-wide association studies (GWAS) for kidney function are promising targets for functional studies, but prioritizing variants and genes is challenging. By GWAS meta-analysis for creatinine-based estimated glomerular filtration rate (eGFR) from the Chronic Kidney Disease Genetics Consortium and UK Biobank (n = 1,201,909), we expand the number of eGFRcrea loci (424 loci, 201 novel; 9.8% eGFRcrea variance explained by 634 independent signal variants). Our increased sample size in fine-mapping (n = 1,004,040, European) more than doubles the number of signals with resolved fine-mapping (99% credible sets down to 1 variant for 44 signals, ≤5 variants for 138 signals). Cystatin-based eGFR and/or blood urea nitrogen association support 348 loci (n = 460,826 and 852,678, respectively). Our customizable tool for Gene PrioritiSation reveals 23 compelling genes including mechanistic insights and enables navigation through genes and variants likely relevant for kidney function in human to help select targets for experimental follow-up.
- 16 July 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-17
Top Cited PapersOpen AccessDiscovery and prioritization of variants and genes for kidney function in >1.2 million individuals
Genes underneath signals from genome-wide association studies (GWAS) for kidney function are promising targets for functional studies, but prioritizing variants and genes is challenging. By GWAS meta-analysis for creatinine-based estimated glomerular filtration rate (eGFR) from the Chronic Kidney Disease Genetics Consortium and UK Biobank (n = 1,201,909), we expand the number of eGFRcrea loci (424 loci, 201 novel; 9.8% eGFRcrea variance explained by 634 independent signal variants). Our increased sample size in fine-mapping (n = 1,004,040, European) more than doubles the number of signals with resolved fine-mapping (99% credible sets down to 1 variant for 44 signals, ≤5 variants for 138 signals). Cystatin-based eGFR and/or blood urea nitrogen association support 348 loci (n = 460,826 and 852,678, respectively). Our customizable tool for Gene PrioritiSation reveals 23 compelling genes including mechanistic insights and enables navigation through genes and variants likely relevant for kidney function in human to help select targets for experimental follow-up.